Article
Nationwide experience of catecholaminergic polymorphic ventricular tachycardia caused by RyR2 mutations.
Heart (British Cardiac Society) - 1 Jun 2017
Broendberg Anders Krogh, Nielsen Jens Cosedis, Bjerre Jesper, Pedersen Lisbeth Noerum, Kristensen Jens, Henriksen Finn Lund, Bundgaard Henning, Jensen Henrik Kjaerulf
Abstract excerpt
OBJECTIVE: The aim of this study was to characterise disease penetrance, course of disease and use of antiarrhythmic medication and implantable cardioverter-defibrillator (ICD) therapy in a Danish nationwide cohort of patients with catecholaminergic polymorphic ventricular tachycardia (CPVT) due to mutations in the ryanodine receptor-2 (RyR2) gene. METHODS: The study population was identified through the national...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
